Benznidazole, a drug used in Chagas' disease, ameliorates LPS-induced inflammatory response in mice
- 24 December 2004
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 76 (6), 685-697
- https://doi.org/10.1016/j.lfs.2004.09.013
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Experimental Chemotherapy againstTrypanosoma cruziInfection: Essential Role of Endogenous Interferon‐γ in Mediating Parasitologic CureThe Journal of Infectious Diseases, 2002
- Treatment with benznidazole and its immunomodulating effects on Trypanosoma cruzi -infected ratsZeitschrift für Parasitenkunde, 2001
- Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)The Journal of Experimental Medicine, 1999
- Molecular basis of host—pathogen interaction in septic shockCurrent Opinion in Microbiology, 1998
- NITRIC OXIDE AND MACROPHAGE FUNCTIONAnnual Review of Immunology, 1997
- Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance.JCI Insight, 1995
- NITRIC OXIDE: A Physiologic Messenger MoleculeAnnual Review of Biochemistry, 1994
- Interleukin‐10 controls interferon‐γ and tumor necrosis factor production during experimental endotoxemiaEuropean Journal of Immunology, 1994
- The Pathophysiology of Tumor Necrosis FactorsAnnual Review of Immunology, 1992
- CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding ProteinScience, 1990